Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa trial of topical tarenflurbil spray in mild to moderate atopic eczema
2011-002571-42Phase 2Completed
- Sponsor
- GALENpharma GmbH
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing Tarenflurbil spray with Vehicle control (2 arms). Started Oct 2011; status: completed.
02
Drugs
tarenflurbil
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2011-002571-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002571-42.